Obesity Featured Articles

  1. 2026 Forecasts From People Smarter Than Me – Part 1 12/12/2025

    In Part 1 of this forecast series, leaders from TransCelerate, Genentech, Clinical Performance Partners, Marketcap Consulting, and others weigh in on what’s coming next — from regulatory pressure and RBQM mandates to BYOT momentum, AI reality checks, and the financial rebound many CROs are betting on.

  2. Can't-Miss Advice On Selecting Your First AI-Enabled Vendor 12/12/2025

    Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.

  3. Hidden Costs Of Data Cleaning: Build Quality At The Source 12/11/2025

    Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.

  4. Aligning Global Standards For ICH E6(R3) And Artificial Intelligence 12/11/2025

    Global standards and AI are transforming clinical research. Learn why mastering ICH E6(R3) and risk-based compliance is critical for data integrity and future success.

  5. Securing Sponsor Reimbursement For CRIO Fees 12/11/2025

    Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.

  6. More Than Technology: How People Make The Difference For Customers 12/11/2025

    Technology alone doesn’t guarantee success. Here, we explain how integrated processes, skilled teams, and collaborative partnerships complement innovation to reduce risk and improve patient outcomes.

  7. Clinical Supply's Role In Driving Success In Decentralized Trials 12/11/2025

    Decentralized trials are a challenge for supply chain professionals. Explore how logistics, labeling, and home delivery make or break trial outcomes.

  8. The 2020 Pediatric Mandate That Shook Up Oncology Research 12/11/2025

    Until 2020, the majority of drugs used in pediatric medicine had not been studied adequately in children. Regulatory expert Bhargavi Pandit recounts the impact the U.S. RACE for Children Act had on pediatric and adult investigational drug trials.

  9. Site Engagement Improves Study Support And Results 12/10/2025

    Dedicated site engagement helps reduce administrative burden, improve participant access, and keep studies moving. This approach strengthens workflows and supports sites throughout every phase.

  10. Year-In-Review: Clinical Research Today And Tomorrow 12/10/2025

    As the industry prepares for 2026, sponsors and investors alike face a pivotal moment — one that demands a more deliberate, insight-driven approach to early clinical development.